Using Medipixel XA technology for heart artery procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the effectiveness and safety of Medipixel XA-Assisted Percutaneous Coronary Intervention (MPXA-PCI) in patients with coronary artery disease. It aims to enroll 830 patients with de novo coronary lesions eligible for drug-eluting stent implantation, assessing procedural success rates and clinical outcomes in a real-world setting. Participants will undergo MPXA-assisted lesion assessment to optimize treatment selection, with primary outcomes focusing on target vessel failure at 12 months. Secondary outcomes include procedural success, angiographic results, and complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Silent ischemia, stable or unstable angina, or myocardial infarction
* De novo coronary lesion eligible for DES implantation
* Lesions analyzable by MPXA

Exclusion Criteria:

* Comorbidity with a life expectancy \<12 months
* Intolerant of antithrombotic therapy
* Significant anemia, thrombocytopenia, or leucopenia
* History of major hemorrhage (intracranial, gastrointestinal, and so on)
* Chronic total occlusion lesion
* Left main lesion
* Severe calcification needing rotational atherectomy
* Lesions not analyzable by MPXA

Where it's running

• Chung-Ang University Gwangmyeong Hospital
  Gwangmyeong, Gyeonggi-do, South Korea Recruiting
• CHA Bundang Medical Center
  Seongnam-si, Gyeonggi-do, South Korea Recruiting
• Keimyung University Dongsan Medical Center
  Daegu, South Korea Recruiting
• Chonnam National University Hospital
  Gwangju, South Korea Recruiting
• Presbyterian Medical Center
  Jeonju, South Korea Recruiting
• Ulsan University Hospital
  Ulsan, South Korea Recruiting

Study contacts

• Study coordinator: Hwa-In Kim
• Email: niawhz23@gmail.com
• Phone: +82-31-780-5858

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Revascularization of Calcified Coronary Arteries

  This study tests whether measuring blood flow and pressure before and after ballooning or stenting of calcified coronary arteries can help predict how well the procedure will work for adults with heart disease.

  Recruiting Aalborg University Hospital · Aalborg · NCT07724184

• Switching from clopidogrel to low-dose prasugrel after PCI in people at high bleeding and ischemic risk

  We will test whether switching adults who had PCI and are at both high bleeding and ischemic risk from standard-dose clopidogrel to low-dose prasugrel lowers platelet reactivity compared with staying on clopidogrel.

  Recruiting Phase 4 University of Florida · Jacksonville, Florida · NCT07025148

• Comparing two techniques for treating complex coronary bifurcation lesions

  This study is testing two different ways to treat complex heart artery blockages to see which one helps patients feel better and have fewer heart problems after the procedure.

  Recruiting at 2 sites Istanbul Mehmet Akif Ersoy Educational and Training Hospital · Istanbul and 1 other locations · NCT06931574

• Optimal stent deployment strategy for thinner-strut bioresorbable scaffolds guided by intracoronary imaging

  This study tests whether using a thinner-strut bioresorbable scaffold with OCT/IVUS imaging guidance improves outcomes in adults with stable CAD undergoing PCI.

  Recruiting Albert Schweitzer Ziekenhuis, Netherlands · Dordrecht · NCT06919562

• Reduced-dose prasugrel alone after PCI in acute and chronic coronary syndrome

  This test tries whether taking a low 5 mg daily dose of prasugrel alone after a successful PCI can prevent clots while lowering bleeding risk in people with acute or chronic coronary syndromes.

  Recruiting Phase 4 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06916520

• Comparing orbital atherectomy and intravascular lithotripsy for calcified coronary nodules

  This pilot trial will see if orbital atherectomy or intravascular lithotripsy better prepares OCT-identified calcified coronary nodules for stent placement in adults with coronary artery disease.

  Recruiting at 6 sites Spanish Society of Cardiology · Alicante, Alicante and 5 other locations · NCT06736665

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.